The company is engaged in production of leading generic APIs, Nutraceutical ingredients and custom synthesis of APIs and intermediates for global companies.
It has a product portfolio of 122 products across various therapeutic areas.
Current Price
₹ 3,278
Stock P/E
29.1 , after 3 years it is back to Median PE of 29
Book Value
₹ 457
Promoter holding
51.9 %
Debt
₹ 3.29 Cr.
Pledged percentage
0.00 %
Debt to equity
0.00
Price to book value
7.13
PEG Ratio
1.28
Stock is below 200 / 100 / 63/21/10 EMA
BELOW 50% Retracement in Fibnocci
Can be accumulated for long-term / SIP , considering its fundamentals
It has a product portfolio of 122 products across various therapeutic areas.
Current Price
₹ 3,278
Stock P/E
29.1 , after 3 years it is back to Median PE of 29
Book Value
₹ 457
Promoter holding
51.9 %
Debt
₹ 3.29 Cr.
Pledged percentage
0.00 %
Debt to equity
0.00
Price to book value
7.13
PEG Ratio
1.28
Stock is below 200 / 100 / 63/21/10 EMA
BELOW 50% Retracement in Fibnocci
Can be accumulated for long-term / SIP , considering its fundamentals